Phagosomal and model lipid membranes

Phagosomal membranes are specialized lipid bilayers that form during the process of phagocytosis to engulf and isolate extracellular materials, such as pathogens or apoptotic cells, for subsequent degradation (Fairn & Grinstein, 2012, Nature Reviews Molecular Cell Biology). These membranes are not static; they undergo a rapid maturation process characterized by sequential fusion and fission events with endocytic compartments, eventually forming the phagolysosome (Flannagan et al., 2009, Nature Reviews Microbiology). Model lipid membranes, such as liposomes, supported lipid bilayers, and giant unilamellar vesicles, are synthetic tools used by researchers to simulate these biological barriers and study the biophysical interactions between drugs and cellular surfaces (Peetla et al., 2009, Molecular Pharmaceutics). While these membranes are essential for innate immunity and cellular homeostasis, they are generally classified as cellular structures or experimental models rather than specific molecular therapeutic targets like receptors or enzymes. However, the phagosomal environment is a critical interface in infectious diseases, as pathogens like Mycobacterium tuberculosis have evolved mechanisms to arrest membrane maturation and survive within the host (Russell, 2001, Nature Reviews Molecular Cell Biology). Drugs that interact with lipid membranes, such as the antifungal Amphotericin B or the antibiotic Daptomycin, typically work by disrupting bilayer integrity or binding to specific lipid species, though they are rarely designed to target phagosomal membranes specifically (Mouritsen, 2011, Lipids, Liposomes, and Membrane Pharmacotherapy).

Other names

Phagosome membraneModel lipid bilayersArtificial membranesLiposomesLipid bilayers

Disruption of lipid bilayer integrity, pore formation, or sequestration of membrane lipids to alter permeability and induce cell death.